Table 3.
Association of TyG index with the different phases of coronary artery disease
| Coronary artery disease (n = 1966) | TyG index tertiles | ||
|---|---|---|---|
| 1 (lowest) | 2 | 3 (highest) | |
| PR (95% CI) | |||
| Asymptomatic (n = 380) | |||
| Model 1 | Ref. | 0.94 (0.75–1.18) | 0.97 (0.78–1.22) |
| Model 2 | Ref. | 0.93 (0.74–1.17) | 0.98 (0.79–1.23) |
| Model 3 | Ref. | 0.93 (0.74–1.17) | 0.98 (0.78–1.17) |
| Symptomatic (n = 844) | |||
| Model 1 | Ref. | 1.09 (0.95–1.25) | 1.17 (1.03–1.34) |
| Model 2 | Ref. | 1.09 (0.95–1.25) | 1.17 (1.03–1.35) |
| Model 3 | Ref. | 1.08 (0.94–1.24) | 1.16 (1.01–1.33) |
| Treated (n = 1607) | |||
| Model 1 | Ref. | 1.07 (1.01–1.14) | 1.05 (0.98–1.13) |
| Model 2 | Ref. | 1.07 (1.01–1.15) | 1.05 (0.98–1.12) |
| Model 3 | Ref. | 1.05 (0.99–1.13) | 1.03 (0.97–1.10) |
Data are prevalence ratio (95% CI) based in Poisson regression
Italic values show the presence of statistic significance
Model 1: crude
Model 2: adjusted by sex and age
Model 3: adjusted by model 2, use of hypoglycemic, antihypertensive, anticoagulant, lipid-lowing agents, carbohydrate and lipids intake, stroke, peripheral artery disease, and the presence of any other stage of the disease